The University of Miami Health System’s Sylvester Comprehensive Cancer Center is utilizing ViewRay’s MRIdian system to treat patients with MRI-guided radiation therapy. MRIdian, which integrates MR technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of tumors while radiation is delivered, provides continuous soft-tissue imaging during radiation treatment. Such technology enables clinicians to continuously view the tumor they’re treating, ViewRay officials say.
Alan Pollack, MD, PhD, chair of radiation oncology at Sylvester, calls the increased visibility a game-changer for hospital physicians. “The ability to view the tumor and normal tissues in real-time using MRI-guidance is a huge advance in radiation therapy, which we expect to benefit patients through improvements in tumor control and reduced toxicity,” Pollack says.
“We’re proud to offer this advanced cancer treatment to patients within Florida and beyond,” he adds.
In addition to Sylvester, the MRIdian system is treating patients at global cancer centers including the University of California, Los Angeles’ Jonsson Comprehensive Cancer Center; the Siteman Cancer Center at Barnes?Jewish Hospital and Washington University School of Medicine in St Louis; the Madison-based University of Wisconsin Carbone Cancer Center; and Korea’s Seoul National University Hospital. Malignancies treated include lung, liver, prostate, breast, bladder, and head and neck tumors.
For more information about this technology, visit ViewRay.
